在胰腺癌中外体LncRNAs的进展
Chengyan Wei1, Chunwei Zhang1, Yuanzhi Zhou1
1School of Pharmacy, Anhui Medical University, Hefei 230032, China.
International journal of molecular sciences
|August 29, 2024
概括
外体长非编码RNAs (lncRNAs) 显示出作为胰腺癌的生物标志物和治疗点的希望. 这些分子调节瘤生长和治疗反应,为早期检测和治疗提供了新的途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 胰腺癌存在重大挑战,原因是药物耐药性和死亡率的增加.
- 缺乏特定的生物标志物和治疗点,阻碍了胰腺癌的早期检测和有效治疗.
- 外体长非编码RNA (lncRNAs) 是外体内稳定的分子,能够进行细胞间通信.
研究的目的:
- 对外体 lncRNAs 的特征进行审查.
- 探索它们在胰腺癌发病和进展中的生物学作用.
- 突出其作为诊断生物标志物和治疗点的潜力.
主要方法:
- 在胰腺癌中对外体lncRNA的研究的文献综述.
- 对外体lncRNA作为瘤基因或瘤抑制剂的功能进行分析.
- 评估它们对瘤生长,转移和治疗反应的影响.
主要成果:
- 外体 lncRNAs 丰富且稳定,在细胞间信号传递中起作用.
- 这些lncRNAs影响胰腺癌的发展,包括生长,转移以及对化疗和辐射的反应.
- 证据支持它们作为瘤基因和瘤抑制剂的作用.
结论:
- 外体 lncRNAs 是胰腺癌的有前途的诊断生物标志物.
- 它们有潜力成为胰腺癌治疗的新型治疗点.
- 对外体 lncRNAs 的进一步研究可以显著改善患者的治疗结果.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
01:36Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K